Inducible silencing of PRKD3 inhibits secretion of tumor-promoting factors (matrix metallopeptidase 9, Interleukin 6, C-X-C motif chemokine ligand 8, and C-X-C motif chemokine ligand 1) in prostate cancer 39. Here, PRKD3 is linked to prostate carcinoma.